NCT03080545View on ClinicalTrials.gov

Enstilar in Combination With Biologic Agents

PHASE4CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

October 30, 2017

Study Completion Date

October 30, 2017

Conditions

Psoriasis

Interventions

DRUG

Enstilar 0.005%-0.064% Topical Foam

Topical foam

Trial Locations (1)

08520

Psoriasis Treatment Center of Central New Jersey, East Windsor

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

LEO Pharma

INDUSTRY

lead

Psoriasis Treatment Center of Central New Jersey

OTHER